(Q40355783)

English

M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells

scientific article published on 2 November 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

endometrial cancer

1 reference

based on heuristic

inferred from title

author name string

Noriyuki Takai

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tami Ueda

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Masakazu Nishida

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kaei Nasu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Hisashi Narahara

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

2 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

108-113

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Class II histone deacetylases: versatile regulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Histone deacetylases (HDACs): characterization of the classical HDAC family

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Increased surface phosphatidylserine is an early marker of neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Cyclins and cell cycle checkpoints

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Cadherin cell adhesion receptors as a morphogenetic regulator

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Butyrate and phenylacetate as differentiating agents: practical problems and opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.044

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.09.044

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40355783&oldid=1940095774"